115372 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39034)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22057)
  4. Surgery (21249)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15763)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5599)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115372)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of compliance with payer-led oncology clinical pathways
    Meeting Abstract

    Mullangi, S.; Chen, X.; Pham, T.; Liu, Y.; Gordon, A.; Debono, D. J.; Fisch, M. J.; Gonen, M.; Hershman, D. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A multidisciplinary approach to operationalizing financial toxicity interventions: The MSK Affordability Working Group
    Meeting Abstract

    Aviki, E. M.; Chino, F.; Gany, F.; Caramore, A.; Doyle, S.; Liebhaber, A.; Newman, T.; Sokolowski, S.; Thom, B.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of telaglenastat plus cabozantinib vs placebo plus cabozantinib in patients with advanced renal cell carcinoma: The CANTATA randomized clinical trial
    Journal Article

    Tannir, N. M.; Agarwal, N.; Porta, C.; Lawrence, N. J.; Motzer, R.; McGregor, B.; Lee, R. J.; Jain, R. K.; Davis, N.; Appleman, L. J.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Abbreviated breast MRI utilization: A survey of the Society of Breast Imaging
    Journal Article

    Grimm, L. J.; Conant, E. F.; Dialani, V. M.; Dontchos, B. N.; Harvey, J. A.; Kacharia, V. S.; Plecha, D. M.; Mango, V. L.
    Journal of Breast Imaging (2022)

    Fulltext@MSK | Save
  • Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer
    Meeting Abstract

    Oktay, K. H.; Turan, V.; Bedoschi, G.; Goldfarb, S.; Bang, H.
    Fertility and Sterility (2022)

    Fulltext@MSK | Save
  • Knowledge on the relationship between highly prevalent sexually transmitted infections & infertility among the downtown Detroit African American population
    Meeting Abstract

    Gonullu, D. C.; Rausch, J.; Huang, X. M.; Awonuga, A. O.
    Fertility and Sterility (2022)

    Fulltext@MSK | Save
  • Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor
    Meeting Abstract

    Schram, A.; Borad, M.; Sahai, V.; Kamath, S.; Kim, R.; Liao, C. Y. A.; Oh, D. Y.; Ponz-SarviseĢ, M.; Yachnin, J.; Shell, S. A.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Detection of euploid pregnancy loss fingerprint from serum via quantum defect-modified carbon nanotube arrays
    Meeting Abstract

    Bortoletto, P.; Kim, M.; Gwynne, D.; Randall, E. A.; James, D.; Heller, D. A.
    Fertility and Sterility (2022)

    Fulltext@MSK | Save
  • Lineage plasticity in prostate cancer depends on FGFR and JAK/STAT inflammatory signaling
    Meeting Abstract

    Chan, J.; Zaidi, S.; Love, J.; Zhao, J.; Setty, M.; Wadosky, K.; Gopalan, A.; Choo, Z. N.; Persad, S.; Chaudhary, O.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • CDK12 loss leads to replication stress and sensitivity to combinations of the ATR inhibitor camonsertib (RP-3500) with PARP inhibitors
    Meeting Abstract

    Setton, J.; Gallo, D.; Glodzik, D.; Kaiser, B.; Braverman, S.; Ubhi, T.; Fournier, S.; Selenica, P.; Laterreur, N.; Roulston, A.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save